Drug profile · INN
eftrenonacog alfa
ALPROLIX
eftrenonacog alfa (ALPROLIX) is a coagulation factor ix exogenous protein.
EMA: approved Blood and blood forming organs (B02) B02BD04
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — eftrenonacog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
eftrenonacog alfa (ALPROLIX) is a coagulation factor ix exogenous protein.
Key facts
INN eftrenonacog alfa
Brand ALPROLIX
Mechanism Coagulation factor IX exogenous protein
Target Coagulation factor IX
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD04
Mechanism of action
Coagulation factor IX exogenous protein
Primary target: Coagulation factor IX
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is eftrenonacog alfa?
eftrenonacog alfa (ALPROLIX) is a coagulation factor ix exogenous protein.
What is the brand name for eftrenonacog alfa?
ALPROLIX is a marketed brand name for eftrenonacog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.